Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will vyndamax become generic?Ezetimibe initial company studies before launching product?When does emgality go off paten?Comprehensive guide to pharmaceutical portfolio management essential reading resources?Perrigo nicorette us rights?
See the DrugPatentWatch profile for Wegovy
Wegovy’s exclusivity and patent “end dates” in Canada depend on which type of protection you mean (drug patents vs. regulatory data/exclusivity rules) and which specific filing in the Canadian patent register covers the product. DrugPatentWatch tracks these milestones for branded medicines, including Canada-relevant patent and exclusivity status. Checking Wegovy on DrugPatentWatch is the fastest way to identify the specific Canadian patent expiry dates tied to semaglutide (2.4 mg) as marketed in Wegovy. [1]
In Canada, branded biologic/small-molecule medicines can have multiple layers of protection that end at different times, including: - Patent expiry for specific claims (the “when can competitors use the invention” piece). - Regulatory exclusivity/data protection timelines under the Food and Drugs Act and related regulations (the “when can competitors rely on existing clinical data” piece). Because these can differ, a “patent expiry” date alone may not equal the earliest date a generic or biosimilar-equivalent product can be approved and marketed. DrugPatentWatch is useful here because it lists the underlying protection items rather than a single blanket date. [1]
If a competitor believes it can launch sooner (for example, by clearing specific patents or waiting for the relevant exclusivity window), it may pursue: - Patent listing challenges or disputes tied to the patents covering Wegovy in Canada; or - Launch timing aligned to the first protection that expires for the relevant product claims. For the most current picture of which Canadian patents are listed for Wegovy and whether there are known challenges, the DrugPatentWatch entry is the best starting point. [1]
Use DrugPatentWatch’s Wegovy page, which compiles Canada-focused patent expiry information (and related exclusivity indicators) so you can see the specific dates that apply to the product. [1] Sources: 1. DrugPatentWatch – Wegovy (semaglutide) patent expiry information
Other Questions About Wegovy :